140-Gene signature correlates with enhanced disease-free survival in NSCLC patients treated with durvalumab and low-dose radiation
A groundbreaking study has recently identified a cluster of 140 genes that may serve as a predictive tool for improved disease-free survival among patients grappling… Read More »140-Gene signature correlates with enhanced disease-free survival in NSCLC patients treated with durvalumab and low-dose radiation